Respiratory Infections News

Fewer patients with community-acquired pneumonia using corticosteroids vs. standard care needed mechanical ventilation, but mortality rates did not differ between both groups, according to study results published in CHEST.

The FDA on Monday approved a monoclonal antibody for the prevention of respiratory syncytial virus lower respiratory tract disease in newborn and infants.

Infliximab was found to be safe and effective as adjunctive therapy for patients with central nervous system tuberculosis, researchers reported.

American Indian and Alaska Native children endure high rates of respiratory syncytial virus infection, a study published in Pediatrics found.

Paxlovid lowers the risk for severe COVID-19 among younger vaccinated adults with at least one serious comorbidity, researchers found, although their study did not see the same benefit for patients without medical comorbidities.

Thousands of samples taken from white-tailed deer in the U.S. showed that SARS-CoV-2 was transmitted from humans to deer more than 100 times, mutated, and then was potentially transmitted back to humans in three cases, researchers reported.

Risk for all-cause, nonaccidental and neoplasm mortality was heightened with exposure to elevated levels of wildfire-related fine particulate matter, according to study results published in the Journal of Hazardous Materials.

A study of more than 50 adults with a serious inflammatory syndrome linked to SARS-CoV-2 infection found that fewer than half were diagnosed with the condition while they were hospitalized.

Evidence from multiple trials suggests that higher dose corticosteroids “probably” lessen the mortality risk among patients with severe to critical COVID-19, according to study results published in Annals of the American Thoracic Society.

Exposure to elevated levels of air pollutants before COVID-19 hospitalization increased length of hospital stay and risk for ICU admission, according to study results published in European Respiratory Journal.